PT Kalbe Farma Tbk Share Price INDONESIA S.E.
Equities
KLBF
ID1000096803
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- IDR | - |
17/05 | Nomura Adjusts Kalbe Farma’s Price Target to 1,900 Rupiahs From 1,850 Rupiahs, Keeps at Buy | MT |
30/04 | PT Kalbe Farma Tbk. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 32,575B 1.99B 167B | Sales 2025 * | 34,865B 2.13B 179B | Capitalization | 72,390B 4.42B 372B |
---|---|---|---|---|---|
Net income 2024 * | 3,150B 192M 16.17B | Net income 2025 * | 3,497B 213M 17.95B | EV / Sales 2024 * | 2.11 x |
Net cash position 2024 * | 3,714B 227M 19.07B | Net cash position 2025 * | 4,906B 299M 25.19B | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
23.3
x | P/E ratio 2025 * |
20.9
x | Employees | - |
Yield 2024 * |
2.1% | Yield 2025 * |
2.13% | Free-Float | 40.44% |
Managers | Title | Age | Since |
---|---|---|---|
Vidjongtius
CEO | Chief Executive Officer | 59 | 01/97/01 |
Chairman | 62 | 01/97/01 | |
Danny Natalies
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Santoso Oen
BRD | Director/Board Member | 60 | 01/00/01 |
Chairman | 62 | 01/97/01 | |
Ronny Hadiana
BRD | Director/Board Member | 52 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
+50.32% | 781B | |
-7.32% | 350B | |
+18.68% | 330B | |
+7.15% | 293B | |
+16.91% | 248B | |
+0.53% | 221B | |
+11.06% | 217B | |
+3.49% | 162B | |
-4.05% | 157B |
- Stock Market
- Equities
- KLBF Stock
- KLBF Stock